and sold as `Non-Drowsy,’” but actually contained dextromethorphan, which may cause drowsiness, the settlement website said. Haleon, Robitussin’s manufacturer, denied any wrongdoing and ...
Buyers of Robitussin can now apply to get money from a class-action lawsuit that began in 2022 over the cough medicine being marketed as "non-drowsy." Consumers can get $1.50 to $4.75 per claim ...
and sold certain Robitussin products as "Non-Drowsy" because they contain dextromethorphan ("DXM"), an ingredient Plaintiffs claim can cause drowsiness. What does the Settlement provide?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback